🕵️ First Tracks Biotherapeutics, Inc. ($TRAX)
SEC insider & ownership activity, last 12 months · CIK 2091349 · every row links its SEC filing
Over the last 12 months insiders sold $65.0M with no open-market buying against it. ECOR1 Capital, LLC sold $65.0M in discretionary trades (Apr). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $65.0M (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| ECOR1 Capital, LLC | 0 | – | 1 | $65.0M | Apr 20, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| ECOR1 Capital, LLC | 9.1% | 13G | Apr 22, 2026 | filing ↗ | |
| Oleg Nodelman | 9.1% | 13G | Apr 22, 2026 | filing ↗ | |
| ECOR1 Capital Fund Qualified, L.P. | 8.5% | 13G | Apr 22, 2026 | filing ↗ | |
| Blackrock, Inc. | 5.5% | 13G | Jul 28, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 15, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 20, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Apr 20, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 20, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Apr 20, 2026 | filing ↗ |
| Change of control (5.01) | Apr 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 20, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 20, 2026 | filing ↗ |
| Other events (8.01) | Apr 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |